Scopus Biopharma Stock Technical Analysis
| SCPS Stock | USD 0.0004 0.00 0.00% |
As of the 25th of January, Scopus Biopharma has the Coefficient Of Variation of 1038.68, variance of 186.03, and Risk Adjusted Performance of 0.0799. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Scopus Biopharma, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate data for thirteen technical drivers for Scopus Biopharma, which can be compared to its competition. Please validate Scopus Biopharma market risk adjusted performance and treynor ratio to decide if Scopus Biopharma is priced more or less accurately, providing market reflects its prevalent price of 4.0E-4 per share. As Scopus Biopharma appears to be a penny stock we also recommend to double-check its jensen alpha numbers.
Scopus Biopharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Scopus, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ScopusScopus |
Scopus Biopharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Scopus Biopharma's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Scopus Biopharma.
| 10/27/2025 |
| 01/25/2026 |
If you would invest 0.00 in Scopus Biopharma on October 27, 2025 and sell it all today you would earn a total of 0.00 from holding Scopus Biopharma or generate 0.0% return on investment in Scopus Biopharma over 90 days. Scopus Biopharma is related to or competes with Orphazyme. Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics t... More
Scopus Biopharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Scopus Biopharma's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Scopus Biopharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0905 | |||
| Maximum Drawdown | 83.33 | |||
| Value At Risk | (25.00) | |||
| Potential Upside | 33.33 |
Scopus Biopharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Scopus Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Scopus Biopharma's standard deviation. In reality, there are many statistical measures that can use Scopus Biopharma historical prices to predict the future Scopus Biopharma's volatility.| Risk Adjusted Performance | 0.0799 | |||
| Jensen Alpha | 1.23 | |||
| Total Risk Alpha | 0.0298 | |||
| Treynor Ratio | 1.21 |
Scopus Biopharma January 25, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0799 | |||
| Market Risk Adjusted Performance | 1.22 | |||
| Mean Deviation | 6.18 | |||
| Coefficient Of Variation | 1038.68 | |||
| Standard Deviation | 13.64 | |||
| Variance | 186.03 | |||
| Information Ratio | 0.0905 | |||
| Jensen Alpha | 1.23 | |||
| Total Risk Alpha | 0.0298 | |||
| Treynor Ratio | 1.21 | |||
| Maximum Drawdown | 83.33 | |||
| Value At Risk | (25.00) | |||
| Potential Upside | 33.33 | |||
| Skewness | 1.08 | |||
| Kurtosis | 5.91 |
Scopus Biopharma Backtested Returns
Scopus Biopharma is out of control given 3 months investment horizon. Scopus Biopharma owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0985, which indicates the firm had a 0.0985 % return per unit of risk over the last 3 months. We were able to interpolate data for eighteen different technical indicators, which can help you to evaluate if expected returns of 1.38% are justified by taking the suggested risk. Use Scopus Biopharma Coefficient Of Variation of 1038.68, variance of 186.03, and Risk Adjusted Performance of 0.0799 to evaluate company specific risk that cannot be diversified away. Scopus Biopharma holds a performance score of 7 on a scale of zero to a hundred. The entity has a beta of 1.08, which indicates a somewhat significant risk relative to the market. Scopus Biopharma returns are very sensitive to returns on the market. As the market goes up or down, Scopus Biopharma is expected to follow. Use Scopus Biopharma jensen alpha and rate of daily change , to analyze future returns on Scopus Biopharma.
Auto-correlation | 0.00 |
No correlation between past and present
Scopus Biopharma has no correlation between past and present. Overlapping area represents the amount of predictability between Scopus Biopharma time series from 27th of October 2025 to 11th of December 2025 and 11th of December 2025 to 25th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Scopus Biopharma price movement. The serial correlation of 0.0 indicates that just 0.0% of current Scopus Biopharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 0.93 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Scopus Biopharma technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Scopus Biopharma Technical Analysis
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Scopus Biopharma volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Scopus Biopharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Scopus Biopharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Scopus Biopharma based on its technical analysis. In general, a bottom-up approach, as applied to this otc stock, focuses on Scopus Biopharma price pattern first instead of the macroeconomic environment surrounding Scopus Biopharma. By analyzing Scopus Biopharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Scopus Biopharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Scopus Biopharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
Scopus Biopharma January 25, 2026 Technical Indicators
Most technical analysis of Scopus help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Scopus from various momentum indicators to cycle indicators. When you analyze Scopus charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0799 | |||
| Market Risk Adjusted Performance | 1.22 | |||
| Mean Deviation | 6.18 | |||
| Coefficient Of Variation | 1038.68 | |||
| Standard Deviation | 13.64 | |||
| Variance | 186.03 | |||
| Information Ratio | 0.0905 | |||
| Jensen Alpha | 1.23 | |||
| Total Risk Alpha | 0.0298 | |||
| Treynor Ratio | 1.21 | |||
| Maximum Drawdown | 83.33 | |||
| Value At Risk | (25.00) | |||
| Potential Upside | 33.33 | |||
| Skewness | 1.08 | |||
| Kurtosis | 5.91 |
Scopus Biopharma January 25, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Scopus stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.00 | ||
| Daily Balance Of Power | 0.00 | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 0.00 | ||
| Day Typical Price | 0.00 | ||
| Price Action Indicator | 0.00 |
Additional Tools for Scopus OTC Stock Analysis
When running Scopus Biopharma's price analysis, check to measure Scopus Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scopus Biopharma is operating at the current time. Most of Scopus Biopharma's value examination focuses on studying past and present price action to predict the probability of Scopus Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scopus Biopharma's price. Additionally, you may evaluate how the addition of Scopus Biopharma to your portfolios can decrease your overall portfolio volatility.